Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
7(44%)
Results Posted
67%(4 trials)

Phase Distribution

Ph phase_4
2
13%
Ph not_applicable
10
63%
Ph phase_2
1
6%
Ph phase_1
1
6%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 4Post-market surveillance
2(14.3%)
N/ANon-phased studies
10(71.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

16

all time

Status Distribution
Active(7)
Completed(6)
Other(3)

Detailed Status

Completed6
Recruiting6
unknown3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.1%)
Phase 21 (7.1%)
Phase 42 (14.3%)
N/A10 (71.4%)

Trials by Status

completed638%
active_not_recruiting16%
unknown319%
recruiting638%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT05360056Not Applicable

Continuous Glucose Monitoring Following Hospital Discharge

Active Not Recruiting
NCT06474598Phase 2

An Adaptive Design Study of MTX228

Recruiting
NCT04876079Not Applicable

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes

Completed
NCT05571397Phase 1

Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes

Completed
NCT04783441Not Applicable

Use of CGM in Kidney Transplant Recipients

Recruiting
NCT05394844Not Applicable

Diabetes Education With Real-time Continuous Glucose Monitoring

Completed
NCT06283797Not Applicable

Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes

Recruiting
NCT04430608Not Applicable

Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients

Completed
NCT06275971Not Applicable

Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients

Recruiting
NCT05149625Not Applicable

Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy

Recruiting
NCT05491954

Continuous Glucose Monitoring for Various Degrees of Glucose Intolerance

Unknown
NCT05492890

Continuous Glucose Monitoring for Women With Diabetes Mellitus in the Intrapartum and Postpartum Inpatient Care

Unknown
NCT05478070Not Applicable

Continuous Glucose Monitoring for Personal Protective Equipment Evaluation

Unknown
NCT04039763Not Applicable

RT-CGM in Young Adults at Risk of DKA

Recruiting
NCT03670641Phase 4

Remission Through Early Monitored Insulin Therapy - Duration Month

Completed
NCT04413578Phase 4

CGM - Reimagine Primary Care

Completed

All 16 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
16